Regulatory tech leadership Celegence’s focus on AI-enabled regulatory solutions (CAPTIS) and a history of innovation awards position them as a tech-forward partner. Sales opportunities exist in upselling advanced automation and AI-assisted submission capabilities to pharma, biotech, and medical device clients seeking faster, compliant regulatory workflows.

Global regulatory footprint With operations across the US, UK, Europe, and India, Celegence offers multinational regulatory support and local market intelligence. This can be sold as a scalable solution for companies expanding global submissions, maintaining cross-border compliance, or preparing for IVDR/UDI transitions in new regions.

Sustainability positioning Recent CDP Climate Change Assessment and EcoVadis Bronze Medal demonstrate commitment to sustainability and transparency. This opens conversations with ESG-conscious clients and corporates seeking regulatory partners who align with environmental and governance standards in their product lifecycle.

Life sciences specialization Celegence specializes in regulatory strategy, submission management, publishing, and health authority interactions for pharma, devices, and diagnostics. There is a cross-sell opportunity to existing clients in adjacent regulatory needs or to expand CAPTIS adoption across additional product lines and life-cycle stages.

Growth and capabilities A privately held firm with a mid-size workforce and a track record of awards suggests capacity to scale services for mid-market and niche players. Target potential customers in growth phases needing compliant, efficient regulatory operations, enabling faster time-to-market through expanded consulting and technology-enabled delivery.